Literature DB >> 16808782

"Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospital.

Talya Salant1, Pamela S Ganschow, Olufunmilayo I Olopade, Diane S Lauderdale.   

Abstract

BACKGROUND: Despite advances in breast cancer risk assessment and risk reduction technologies, little is still known about how high-risk women make sense of their risk and assess prevention options, particularly among minority and low-income women. Qualitative methods explore the complex meanings and logics of risk and prevention that quantitative approaches overlook.
OBJECTIVE: This study examined how women attending a high risk breast cancer clinic at a public hospital conceptualize their breast cancer risk and think about the prevention options available to them.
METHODS: Semi-structured interviews were used to gather data from 33 high-risk women (75% African American) between May and August 2004. Interview transcripts were analyzed for recurrent themes and patterns.
RESULTS: Despite general awareness of their objective risk status, many women in this study reported they did not feel "high risk" because they lacked signs and symptoms of cancer. Risk was described as an experienced acute problem rather than a statistical possibility. Women also frequently stated that thinking about cancer might cause it to happen and so it is better not to "dwell on it." While screening was welcomed, women were generally skeptical about primary prevention. In particular, preventive therapies were perceived to cause problems and were only acceptable as treatment options for a disease.
CONCLUSIONS: The body of ideas about risk and prevention expressed by this population differ from the medical model. These findings have implications for risk perception research as well as for the efficacy of risk communication and prevention counseling in clinical contexts.

Entities:  

Mesh:

Year:  2006        PMID: 16808782      PMCID: PMC1924720          DOI: 10.1111/j.1525-1497.2006.00461.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  38 in total

1.  New directions for risk communication research: a discussion with additional suggestions.

Authors:  A C Marcus
Journal:  J Natl Cancer Inst Monogr       Date:  1999

Review 2.  An analysis of the concept of risk.

Authors:  L A Jacobs
Journal:  Cancer Nurs       Date:  2000-02       Impact factor: 2.592

3.  Variation in prophylactic surgery decisions.

Authors:  C Julian-Reynier; F Eisinger; G Evans; W Foulkes; H Sobol
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

Review 4.  Risk-reduction mastectomy: clinical issues and research needs.

Authors:  M Stefanek; L Hartmann; W Nelson
Journal:  J Natl Cancer Inst       Date:  2001-09-05       Impact factor: 13.506

5.  Surveillance or surgery? A description of the factors that influence high risk premenopausal women's decisions about prophylactic oophorectomy.

Authors:  N Hallowell; I Jacobs; M Richards; J Mackay; M Gore
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

6.  Cultural aspects of cancer genetics: setting a research agenda.

Authors:  B Meiser; M Eisenbruch; K Barlow-Stewart; K Tucker; Z Steel; D Goldstein
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

7.  Radical prostatectomy: men's experiences and postoperative needs.

Authors:  Jean Burt; Kate Caelli; Katherine Moore; Melissa Anderson
Journal:  J Clin Nurs       Date:  2005-08       Impact factor: 3.036

8.  Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing.

Authors:  C Lerman; C Hughes; R T Croyle; D Main; C Durham; C Snyder; A Bonney; J F Lynch; S A Narod; H T Lynch
Journal:  Prev Med       Date:  2000-07       Impact factor: 4.018

9.  Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.

Authors:  Victor R Grann; Judith S Jacobson; Dustin Thomason; Dawn Hershman; Daniel F Heitjan; Alfred I Neugut
Journal:  J Clin Oncol       Date:  2002-05-15       Impact factor: 44.544

10.  Breast cancer risk perception: what do we know and understand?

Authors:  P Hopwood
Journal:  Breast Cancer Res       Date:  2000-08-18       Impact factor: 6.466

View more
  33 in total

Review 1.  Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.

Authors:  Mary E Ropka; Jess Keim; John T Philbrick
Journal:  J Clin Oncol       Date:  2010-05-10       Impact factor: 44.544

2.  Development of a brochure for increasing awareness of inherited breast cancer in black women.

Authors:  Susan T Vadaparampil; Gwendolyn P Quinn; Anxhela Gjyshi; Tuya Pal
Journal:  Genet Test Mol Biomarkers       Date:  2011 Jan-Feb

3.  Media messages about cancer: what do people understand?

Authors:  Kathleen M Mazor; Josephine Calvi; Rebecca Cowan; Mary E Costanza; Paul K J Han; Sarah M Greene; Laura Saccoccio; Erica Cove; Douglas Roblin; Andrew Williams
Journal:  J Health Commun       Date:  2010

4.  Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.

Authors:  Laura L Reimers; Parijatham S Sivasubramanian; Dawn Hershman; Mary Beth Terry; Heather Greenlee; Julie Campbell; Kevin Kalinsky; Matthew Maurer; Ramona Jayasena; Rossy Sandoval; Maria Alvarez; Katherine D Crew
Journal:  Breast J       Date:  2015-04-16       Impact factor: 2.431

5.  Chemoprevention Uptake among Women with Atypical Hyperplasia and Lobular and Ductal Carcinoma In Situ.

Authors:  Meghna S Trivedi; Austin M Coe; Alejandro Vanegas; Rita Kukafka; Katherine D Crew
Journal:  Cancer Prev Res (Phila)       Date:  2017-06-13

6.  Deciding on breast cancer risk reduction: The role of counseling in individual decision-making - A qualitative study.

Authors:  Sarah B Blakeslee; Worta McCaskill-Stevens; Patricia A Parker; Christine M Gunn; Hanna Bandos; Therese B Bevers; Tracy A Battaglia; Angela Fagerlin; Jacqueline Müller-Nordhorn; Christine Holmberg
Journal:  Patient Educ Couns       Date:  2017-06-27

7.  Integrating multiple community perspectives in intervention development.

Authors:  Yamilï Molina; Karriem S Watson; Liliana G San Miguel; Karen Aguirre; Mariana Hernandez-Flores; Tatiana B Giraldo; Araceli Lucio; Nora Coronado; Phoenix A Matthews
Journal:  Health Educ Res       Date:  2019-08-01

8.  My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR).

Authors:  Christine Holmberg; Erika A Waters; Katie Whitehouse; Mary Daly; Worta McCaskill-Stevens
Journal:  Med Decis Making       Date:  2015-07-16       Impact factor: 2.583

9.  Women's decisions regarding tamoxifen for breast cancer prevention: responses to a tailored decision aid.

Authors:  Angela Fagerlin; Brian J Zikmund-Fisher; Vijayan Nair; Holly A Derry; Jennifer B McClure; Sarah Greene; Azadeh Stark; Sharon Hensley Alford; Paula Lantz; Daniel F Hayes; Cheryl Wiese; Sarah Claud Zweig; Rosemarie Pitsch; Aleksandra Jankovic; Peter A Ubel
Journal:  Breast Cancer Res Treat       Date:  2010-02       Impact factor: 4.872

10.  Deleterious BRCA1/2 mutations in an urban population of Black women.

Authors:  Filipa Lynce; Karen Lisa Smith; Julie Stein; Tiffani DeMarco; Yiru Wang; Hongkun Wang; Melissa Fries; Beth N Peshkin; Claudine Isaacs
Journal:  Breast Cancer Res Treat       Date:  2015-08-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.